Shuai Gao

9PUBLICATIONS
32CO-AUTHORS
Genome structure and regulationMolecular targetsPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 09, 2026
Minimal-length CAG repeats in AR define a hyperactive AR-LSD1 axis driving metabolic reprogramming in prostate cancer.

|Jun 23, 2026
Identification of targets of clinical FOXA1 mutants involved in EMT and immune suppression in prostate cancer.

|Sep 04, 2023
Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression.

Anna Besschetnova, Wanting Han, Mingyu Liu

|Aug 07, 2023
SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.

Zifeng Wang, Jessica Petricca, Mingyu Liu

|Mar 06, 2023
LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer.

Muqing Li, Mingyu Liu, Wanting Han

|Jan 15, 2022
Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress.

Yiji Liao, Chen-Hao Chen, Tengfei Xiao

Pageof 2

Frequent Collaborators

9 joint publications

Changmeng Cai

5 joint publications

Wanting Han

5 joint publications

Dong Han

5 joint publications

Jill A Macoska